#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3398692	B	Inhibition of OGG1 (unknown origin) pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 to 40 uM by gel-based excision activity assay	Homo sapiens	1		single protein format	Scientific Literature
2.	ALA3398697	B	Inhibition of OGG1 in human A549 cells assessed as reduction in DNA repair at 200 and 300 uM using 8-oxodG-containing M13mp18 plasmids by plasmid based in-cell repair assay	Homo sapiens	1		cell-based format	Scientific Literature
3.	ALA3398699	B	Inhibition of OGG1 in human HeLa cells assessed as reduction in DNA repair at 200 and 300 uM using 8-oxodG-containing M13mp18 plasmids by plasmid based in-cell repair assay	Homo sapiens	1		cell-based format	Scientific Literature
4.	ALA4422180	B	Inhibition of human OGG1 incubated for 30 mins using 8-oxo-Gua-containing substrate by TAMRA fluorescence-based assay	Homo sapiens	20		single protein format	Patent Bioactivity Data
5.	ALA4422181	B	Inhibition of human OGG1 incubated for 30 mins using 8-oxo-Gua-containing substrate by PAGE-based cleavage assay	Homo sapiens	6		single protein format	Patent Bioactivity Data
6.	ALA4422185	B	Inhibition of human OGG1 at 0.08 to 8 uM incubated for 30 mins using 8-oxo-Gua-containing substrate by PAGE-based cleavage assay	Homo sapiens	1		single protein format	Patent Bioactivity Data
7.	ALA4422186	B	Inhibition of human OGG1 assessed as reduction in AP lyase activity using AP-containing substrate	Homo sapiens	7		single protein format	Patent Bioactivity Data
8.	ALA4422187	B	Inhibition of human OGG1 assessed as reduction in free 8-oxo-Gua release using gamma-irradiated calf thymus DNA substrate incubated for 1 hr by GC-MS/MS assay	Homo sapiens	7		single protein format	Patent Bioactivity Data
9.	ALA4422188	B	Inhibition of human OGG1 assessed as reduction in free Inhibition of human OGG1 assessed as reduction in free FapyGua release using gamma-irradiated calf thymus DNA substrate incubated for 1 hr by GC-MS/MS assay	Homo sapiens	7		single protein format	Patent Bioactivity Data
10.	ALA4422204	B	Inhibition of human OGG1 assessed as protection against NaOH-mediated strand cleavage using AP-containing substrate (Rvb = 100%)	Homo sapiens	7		single protein format	Patent Bioactivity Data
11.	ALA4422207	B	Inhibition of human OGG1 binding to 8-oxo-Gua substrate using compound pre-incubated with enzyme for 5 to 10 mins before substrate addition and further incubated for 5 mins by native gel electrophoresis based by gel-shift assay	Homo sapiens	6		single protein format	Patent Bioactivity Data
12.	ALA4422208	B	Inhibition of human OGG1 binding to AP site containing substrate assessed as reduction in AP site binding using compound pre-incubated with enzyme for 5 to 10 mins before substrate addition and further incubated for 5 mins by native gel electrophoresis based by gel-shift assay	Homo sapiens	1		single protein format	Patent Bioactivity Data
13.	ALA4422209	B	Inhibition of human OGG1 catalytic activity assessed as reduction trapping of substrates at 10 uM using 8-oxo-Gua substrate in presence of sodium cyno-borohydride by gel electrophoresis method	Homo sapiens	6		single protein format	Patent Bioactivity Data
14.	ALA4422210	B	Inhibition of human OGG1 catalytic activity assessed as reduction trapping of substrates at 10 uM using AP site containing substrate in presence of sodium cyno-borohydride by gel electrophoresis method	Homo sapiens	6		single protein format	Patent Bioactivity Data
15.	ALA4422211	B	Inhibition of human OGG1 catalytic activity assessed as reduction trapping of substrates using 8-oxo-Gua substrate by measuring concentration of compound needed to reduce borohydride trapping by 50% in presence of sodium cyno-borohydride by gel electrophoresis method	Homo sapiens	2		single protein format	Patent Bioactivity Data
16.	ALA4422212	B	Inhibition of human OGG1 catalytic activity assessed as reduction trapping of substrates using AP site containing substrate by measuring concentration of compound needed to reduce borohydride trapping by 50% in presence of sodium cyno-borohydride by gel electrophoresis method	Homo sapiens	2		single protein format	Patent Bioactivity Data